Brian T. Powl - Net Worth and Insider Trading

Brian T. Powl Net Worth

The estimated net worth of Brian T. Powl is at least $164,584 dollars as of 2024-09-20. Brian T. Powl is the Chief Commercial Officer of Fate Therapeutics Inc and owns about 41,146 shares of Fate Therapeutics Inc (FATE) stock worth over $164,584. Details can be seen in Brian T. Powl's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brian T. Powl has not made any transactions after 2023-07-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Brian T. Powl

To

Brian T. Powl Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brian T. Powl owns 2 companies in total, including Fate Therapeutics Inc (FATE) , and Kura Oncology Inc (KURA) .

Click here to see the complete history of Brian T. Powl’s form 4 insider trades.

Insider Ownership Summary of Brian T. Powl

Ticker Comapny Transaction Date Type of Owner
FATE Fate Therapeutics Inc 2023-07-05 Chief Commercial Officer
KURA Kura Oncology Inc 2023-08-14 Chief Commercial Officer

Brian T. Powl Latest Holdings Summary

Brian T. Powl currently owns a total of 1 stock. Brian T. Powl owns 41,146 shares of Fate Therapeutics Inc (FATE) as of July 5, 2023, with a value of $164,584.

Latest Holdings of Brian T. Powl

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FATE Fate Therapeutics Inc 2023-07-05 41,146 4.00 164,584

Holding Weightings of Brian T. Powl


Brian T. Powl Form 4 Trading Tracker

According to the SEC Form 4 filings, Brian T. Powl has made a total of 1 transactions in Fate Therapeutics Inc (FATE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Fate Therapeutics Inc is the sale of 3,854 shares on July 5, 2023, which brought Brian T. Powl around $18,769.

Insider Trading History of Brian T. Powl

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Brian T. Powl Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Brian T. Powl Ownership Network

Ownership Network List of Brian T. Powl

No Data

Ownership Network Relation of Brian T. Powl

Insider Network Chart

Brian T. Powl Owned Company Details

What does Fate Therapeutics Inc do?

Who are the key executives at Fate Therapeutics Inc?

Brian T. Powl is the Chief Commercial Officer of Fate Therapeutics Inc. Other key executives at Fate Therapeutics Inc include Chief Financial Officer Dulac Edward J Iii , director & President and CEO J Scott Wolchko , and Chief Development Officer Bahram Valamehr .

Fate Therapeutics Inc (FATE) Insider Trades Summary

Over the past 18 months, Brian T. Powl made 1 insider transaction in Fate Therapeutics Inc (FATE) with a net sale of 3,854. Other recent insider transactions involving Fate Therapeutics Inc (FATE) include a net purchase of 44,630 shares made by Redmile Group, Llc , a net sale of 18,777 shares made by Dulac Edward J Iii , and a net sale of 4,725 shares made by Yuan Xu .

In summary, during the past 3 months, insiders sold 633 shares of Fate Therapeutics Inc (FATE) in total and bought 0 shares, with a net sale of 633 shares. During the past 18 months, 393,126 shares of Fate Therapeutics Inc (FATE) were sold and 346,969 shares were bought by its insiders, resulting in a net sale of 46,157 shares.

Fate Therapeutics Inc (FATE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Fate Therapeutics Inc Insider Transactions

No Available Data

Brian T. Powl Mailing Address

Above is the net worth, insider trading, and ownership report for Brian T. Powl. You might contact Brian T. Powl via mailing address: C/o Fate Therapeutics, Inc., 12278 Scripps Summit Drive, San Diego Ca 92131.

Discussions on Brian T. Powl

No discussions yet.